Bastiaan Maes

6PUBLICATIONS
70CO-AUTHORS
Cardiology (incl. cardiovascular diseases)AutoimmunityImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 23, 2023
A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

Karel F A Van Damme, Levi Hoste, Jozefien Declercq

|Jun 22, 2023
STE20 kinase TAOK3 regulates type 2 immunity and metabolism in obesity.

Bastiaan Maes, Farzaneh Fayazpour, Leen Catrysse

|Dec 16, 2021
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

Levi Hoste, Lisa Roels, Leslie Naesens

|Nov 20, 2020
TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells.

Matthias Vanderkerken, Bastiaan Maes, Lana Vandersarren

|Jun 07, 2020
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.

Cedric Bosteels, Bastiaan Maes, Karel Van Damme

|Jun 05, 2020
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.

Bastiaan Maes, Cedric Bosteels, Elisabeth De Leeuw

Pageof 1

Frequent Collaborators

3 joint publications

Manon Vanheerswynghels

3 joint publications

Bart N Lambrecht

2 joint publications

Elisabeth De Leeuw

2 joint publications

Karel F A Van Damme